The company remains a pre-revenue entity with operating losses reaching $467.8K in 2026Q1, driven by rising administrative overhead that has grown from $18.2K in 2024Q1.
| Sales/Revenue | 0 | - | - |
| Revenue Growth % | - | - | - |
| Cost of Goods Sold | 0 | - | - |
| COGS % of Revenue | - | - | - |
| Gross Profit | 0 | 0 | 0 |
| Gross Margin % | - | - | - |
| Gross Profit Growth % | - | - | - |
| Operating Expenses | 1.9M | 1.61M | 400K |
| OpEx % of Revenue | - | - | - |
| Selling, General & Admin | 1.9M | 1.61M | 400K |
| SG&A % of Revenue | - | - | - |
| Research & Development | 0 | - | - |
| R&D % of Revenue | - | - | - |
| Other Operating Expenses | 0 | - | - |
| Operating Income | -1.9M | -1.61M | -400K |
| Operating Margin % | - | - | - |
| Operating Income Growth % | - | -302.77% | - |
| EBITDA | -1.9M | -1.61M | 5.13M |
| EBITDA Margin % | - | - | - |
| EBITDA Growth % | -187.4% | -131.41% | - |
| D&A (Non-Cash Add-back) | 0 | 0 | 0 |
| EBIT | -1.9M | -1.61M | 5.13M |
| Net Interest Income | 9.64M | 9.92M | 5.4M |
| Interest Income | 9.64M | 9.92M | 5.4M |
| Interest Expense | 0 | 0 | 0 |
| Other Income/Expense | 0 | - | - |
| Pretax Income | 7.72M | 8.31M | 5.13M |
| Pretax Margin % | - | - | - |
| Income Tax | 0 | 0 | 0 |
| Effective Tax Rate % | 0% | 0% | 0% |
| Net Income | 7.72M | 8.31M | 5.13M |
| Net Margin % | - | - | - |
| Net Income Growth % | 3.86% | 61.97% | - |
| Net Income (Continuing) | 7.72M | 8.31M | 5.13M |
| Discontinued Operations | 0 | 0 | 0 |
| Minority Interest | 0 | 0 | 0 |
| EPS (Diluted) | 0.34 | 0.29 | 0.26 |
| EPS Growth % | -14.38% | 11.54% | - |
| EPS (Basic) | - | 0.29 | 0.26 |
| Diluted Shares Outstanding | 23M | 23M | 17.67M |
| Basic Shares Outstanding | 23M | 23M | 17.67M |
| Dividend Payout Ratio | - | - | - |
Liquidation deadline execution risk
As indicated by recent financial filings, LPAAU's quarterly SG&A expenses have climbed from $18.2K in 2024Q1 to $467.8K by 2026Q1, reflecting the mounting operational costs inherent in maintaining a public shell vehicle while searching for a viable life sciences merger target.
The steady rise in administrative expenditures suggests that the entity is incurring higher professional and compliance costs as the search for a target intensifies. Investors should monitor whether this burn rate accelerates further, as it directly reduces the net cash available for a potential business combination.
Based on reported figures, LPAAU has consistently recorded positive net income despite zero operational revenue, with 2026Q1 net income reaching $1.7M, a trend driven entirely by interest income on trust assets rather than any underlying business performance or operational success.
The disconnect between negative operating income and positive net income highlights the vehicle's reliance on interest rate environments to sustain its book value. This accounting dynamic warrants caution, as it masks the underlying cash burn required to support the sponsor's search for a target.
According to the income statement data, the company maintains a persistent operating loss, with 2026Q1 operating income at -$467.8K, confirming that the entity lacks any revenue-generating operations to leverage against its fixed administrative cost structure prior to a successful business combination.
The absence of gross profit means that every dollar spent on SG&A directly expands the operating deficit. This structure implies that the entity's financial viability is entirely contingent upon the successful identification and acquisition of an operating business rather than internal efficiency.
As reported in financial statements, the company's operational history shows a clear transition from minimal initial costs to significant quarterly outflows, which may force management into sub-optimal merger decisions as the liquidation deadline approaches and the pressure to deploy capital mounts.
Short-term investors should be wary that the increasing burn rate may incentivize the sponsor to prioritize any deal over a high-quality deal. This potential for 'deal-at-any-cost' behavior remains a primary risk factor for shareholders who are banking on the sponsor's ability to identify superior life science assets.
Quick answers to the most common questions about buying LPAAU stock.
Launch One Acquisition Corp. Unit (LPAAU) is profitable, generating $8.3M in net income for the fiscal year ending 2025.